Digital Edition

CDC data show importance of flu vaccination for pregnant women

New data from the Centers for Disease Control and Prevention emphasize the importance of vaccinating pregnant women against influenza. Read full article.

Anticoagulation update

A monthly review of the
peer-reviewed literature by
Drug Topics' Editorial Advisor
Anna D. Garrett, PharmD, BCPS. Anna Garrett is manager, Outpatient Clinical Pharmacy Programs, Mission Hospital, Asheville, N.C.

Outpatient treatment of pulmonary embolism deemed safe for low-risk patients. Read full article.

Many ADRs are preventable for both inpatients and outpatients, study finds

Many cases of adverse drug reactions in hospitals and emergency care could be prevented, a new study asserts. Read full article.

Meds may be more effective than stenting in intracranial arteries

Intensive medical treatment alone may be more effective than stenting in patients with narrowed arteries in the brain, according to results from the NIH SAMMPRIS trial. Read full article.

FDA approves 2 new indications for denosumab

FDA has approved denosumab for increase of bone mass in certain female patients with breast cancer and certain male patients with nonmetastatic prostate cancer. Read full article.

Meetings and Events

September 26-27, 2011 2nd Annual Pharmaceutical Labeling Summit
Washington, D.C.
Contact:
Jeff Grizzel, Conference Director
FDA News
300 N. Washington St., #200
Falls Church, VA 22046-3431
703-538-7668
[email protected]
www.fdanews.com/PharmaLabeling

October 16-19 ACCP Annual Meeting
Pittsburgh, Pa.
Contact:
http://www.accp.com/meetings/am11/

Connect to Us

Contact a Drug Topics editor Click Here
Contact a Drug Topics sales representative Click Here
Learn about direct mail, reprints and classifieds in Drug Topics Click Here

You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, Click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 866-529-2922 at any time, or
fax us at 218-740-6417. Outside the U.S., please phone 218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.